New drug delays kidney cancer progression
A new type of cancer drug, called a monoclonal antibody, which interferes with a molecule that helps supply blood flow to tumors, increases the length of progression-free survival in patients with
A new type of cancer drug, called a monoclonal antibody, which interferes with a molecule that helps supply blood flow to tumors, increases the length of progression-free survival in patients with